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Abstract Hepatitis B virus (HBV) is classified into genotypes
A^F, which is important for clinical and etiological investiga-
tions. To establish a simple genotyping method, 68 full-genomic
sequences and 106 S gene sequences were analyzed by the
molecular evolutionary method. HBV genotyping with the S gene
sequence is consistent with genetic analysis using the full-
genomic sequence. After alignment of the S sequences, genotype
specific regions are identified and digested by the restriction
enzymes, HphI, NciI, AlwI, EarI, and NlaIV. This HBV
genotyping system using restriction fragment length polymor-
phism (RFLP) was confirmed to be correct when the PCR
products of the S gene in 23 isolates collected from various
countries were digested with this method. A restriction site for
EarI in genotype B was absent in spite of its presence in all the
other genotypes and genotype C has no restriction site for AlwI.
Only genotype E is digested with NciI, while only genotype F has
a restriction site for HphI. Genotype A can be distinguished by a
single restriction enzyme site for NlaIV, while genotype D
digestion with this enzyme results in two products that migrates
at 265 and 186 bp. This simple and accurate HBV genotyping
system using RFLP is considered to be useful for research on
HBV.
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1. Introduction
Hepatitis B virus (HBV) is a partially double-stranded
DNA virus, which is a major causative agent of acute and
chronic hepatitis, liver cirrhosis and hepatocellular carcinoma
in Asian, African and Southern European countries. The
HBV genome has a compact genetic organization with four
open reading frames, C, S, X and P. The P gene covers more
than 70% of the complete genome and overlaps the entire pre-
S and S genes and X and C genes partially [1]. Comparison of
complete HBV genome sequences has revealed genetic clusters
which have been classi¢ed as six di¡erent HBV genotypes
designated A^F [2,3]. An HBV genotype has been de¢ned as
sequences which have a similarity over the whole genome of
about 92% [2]. Since HBV genotypes predominate in certain
geographic areas, there has been speculation about the rela-
tionship between HBV genotypes, development of chronic liv-
er disease and the use of HBV sequences for anthropological
studies [4].
The aims of this study are to con¢rm the classi¢cation of
HBV genotypes by molecular phylogenetic analysis with the
full-genomic sequences and sequences of the S gene, and to
establish a simple HBV genotyping system using restriction
fragment length polymorphism (RFLP) analysis of the S
gene region.
2. Materials and methods
2.1. Phylogenetic tree of the full genome and S gene of HBV
First, 68 full-genomic HBV sequences were retrieved from the DNA
database (DDBJ/GenBank) and aligned to maximize homologies. Ge-
netic distances were estimated using the six-parameter method [5] and
a phylogenetic tree was constructed using the neighbor-joining (N-J)
method [6]. The S genes obtained from these 68 full-genomic sequen-
ces were then analyzed separately using the same method to evaluate
the reliability of this region alone. Finally, these 68 S region sequen-
ces, 11 additional S region sequences from DDBJ/GenBank and 23
newly determined S region sequences were used to construct a phylo-
genetic tree using the same method.
To con¢rm the reliability of the phylogenetic tree, bootstrap resam-
pling tests were performed 1000 times [7].
2.2. Determination of the sequences of the S gene
Twenty-three serum samples were evaluated from patients with
chronic HBV infection in diverse geographic locations including the
Altai in Siberia, Central America, China, Ghana, Japan, the Kam-
chatka peninsula (Siberia), Mongolia, Saudi Arabia and Vietnam. To
amplify HBV DNA by polymerase chain reaction (PCR), DNA ex-
tracted from the serum was added to the following ampli¢cation mix-
ture: 2.5 Wl of 10UEX-Taq polymerase bu¡er (Takara Shuzo Co.,
Japan), 2.5 Wl of 2.5 mM deoxyribonucleotide triphosphate, 0.1 Wl of
EX-Taq (5 units, Takara Shuzo Co., Japan), 10 pmol of sense
(HBV11; 5P-GGGTCACCATATTCTTGGGAACAAGAKCTAC-3P)
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Fig. 1. A: Phylogenetic tree of the full-genomic sequences con-
structed by the neighbor-joining method using 68 full-genomic se-
quences retrieved from DDBJ/GenBank. The names on the tree in-
dicate the accession number of each sequence. On the bootstrap
analysis for evaluation of the statistical reliability of the tree, each
genotype indicates 100%. The horizontal bar indicates the number
of nucleotide substitutions per site. B: Phylogenetic tree of 68 se-
quences of the S gene is also constructed with 68 sequences of the S
gene derived from the 68 full-genomic sequences. The topology of
this tree is the same as that of the full-genomic tree and the reliabil-
ities of genotypes A, B, C, D, E and F are 83.4%, 82.9%, 90.0%,
100%, 82.0% and 100%, respectively. The horizontal bar indicates
the number of nucleotide substitutions per site.
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Fig. 2. Alignment of the sequences of the S gene. The alignment of the sequences of the S gene is shown with representative sequences of each
genotype and the isolates in this study. The restriction enzyme recognition sites are indicated.
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and antisense primers (HBV22; 5P-CAATWCKYTGACANACTTT-
CCAATCARTWGG-3P) in a 25 Wl reaction volume. The ampli¢ca-
tion pro¢le was 2 min at 96‡C, followed by 25 cycles at 94‡C for 15 s
(denaturation), 45 s at 60‡C (annealing) and 45 s at 72‡C (extension),
and was performed in a 96-well cycler (GeneAmp 9600, Perkin-Elmer
Cetus, Norwalk, CT, USA). 1 Wl of the ¢rst-round PCR product was
then added to a second-round PCR mixture with the same composi-
tion but with a set of inner sense (HBMF1; 5P-YCCTGCTGGTGGC-
TCCAGTTC-3P) and antisense primers (HBV22; 5P-CAATWCKYT-
GACANACTTTCCAATCARTWGG-3P). 5 Wl of the second-round
PCR product was then analyzed by electrophoresis in 3% agarose
gels, stained with ethidium bromide, and visualized under ultraviolet
light.
The PCR primers used in this study were designed based on the
most conserved regions derived from the known sequences published
in DDBJ/GenBank. These primers were con¢rmed to be speci¢c for
HBV through a computerized search. The primers were prepared with
a DNA synthesizer (Model 394, Perkin-Elmer Cetus). Standard pre-
cautions for avoiding contamination during PCR were observed. A
negative control serum was also included in each run to ensure spe-
ci¢city.
All the PCR products were ligated into the pGEM-T vector (Prom-
ega, Madison, WI, USA). Positive clones were identi¢ed, expanded,
and sequenced bidirectionally using the dideoxynucleotide chain ter-
mination method (Dye Terminator Cycle Sequencing FS Ready Re-
action Kit, Perkin-Elmer Cetus). The sequences were determined using
a DNA sequencer (ABI Prism 377 DNA Sequencer, Perkin-Elmer
Cetus).
2.3. HBV genotyping by RFLP analysis
To design a genotyping system using RFLP, 85 S gene sequences
were aligned and analyzed to determine the conserved sequences
which were genotype-speci¢c. After identifying the restriction enzyme
sites that identi¢ed genotype-speci¢c sequences, HBV DNA extracted
from the 23 serum samples were ampli¢ed by nested PCR with the
¢rst-round sense (HBMF1; 5P-YCCTGCTGGTGGCTCCAGTTC-3P)
and antisense primers (HBMR2; 5P-AAGCCANACARTGGGGGA-
AAGC-3P) and then the second-round inner sense (HBMF2; 5P-GT-
CTAGACTCGTGGTGGACTTCTCTC-3P) and antisense primers
(HBMR2; 5P-AAGCCANACARTGGGGGAAAGC-3P), under the
same conditions described above. Restriction digestions were carried
out with 5 Wl of the second-round PCR product for 3 h after adjust-
Fig. 3. RFLP pattern of the products of the S gene. Lanes 1^6 indicate HBV genotypes A^F, respectively. 1: Only genotype C was digested by
AlwI. 2: Only genotype B was not digested by EarI. 3: By HphI and NciI, genotypes E and F were digested, resulting in fragments of 379 bp
and 438 bp, respectively, although the other genotypes were 403 bp long. 4: By NlaIV, genotype A was digested into 220 and 265 bp fragments
while genotype D was 186 bp.
Fig. 4. Strategy of the HBV genotyping by RFLP. The second-
round PCR products, which were 485 bp, were digested by AlwI
and EarI to ¢nd genotypes C and B. HphI and NciI digest geno-
types E and F. Finally, genotypes A and D are found by NlaIV.
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ment with 10Uenzyme reaction bu¡er according to the manufactur-
er’s recommendations. Reactions were carried out with 10 units of
AlwI, HphI, NciI, NlaIV or EarI (New England BioLabs) at 37‡C.
The digested PCR products were electrophoresed on 3.0% Nusieve
GTG (3:1) agarose gel in 1UTBE bu¡er (134 mM Tris-HCl, pH
10; 68 mM boric acid; 2.5 mM EDTA) containing 500 ng ethidium
bromide per ml. The RFLP pattern was then evaluated under ultra-
violet light.
3. Results
3.1. Comparison of phylogenetic analysis of complete HBV
genome sequences and S gene sequences
A molecular phylogenetic tree of the 68 full-genomic HBV
sequences was constructed using the N-J method is shown in
Fig. 1A. In this phylogenetic tree, six major genotypes, des-
Fig. 5. Phylogenetic tree of the S gene. This phylogenetic tree was constructed with 85 sequences of the S gene from DDBJ/GenBank and 23
sequences determined in this study which are indicated by an asterisk against the name. The result of the RFLP analysis showed accordance
with the classi¢cation by the phylogenetic tree. AL = Altai, CH = China, CentAM = Central America, GH = Ghana, JA = Japan, KA = Kamchat-
ka, Mon = Mongolia, SAU = Saudi Arabia, and V = Vietnam.
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ignated A^F, are clearly identi¢ed with 100.0% bootstrap val-
ues for each of the major branches. In addition, in the 68
sequences of the S gene, the same genetic clustering of sequen-
ces as that in the full-genomic sequences was identi¢ed by the
phylogenetic tree with 82.0^100.0% bootstrap values. Thus,
based upon these analyses, HBV genotypes can be classi¢ed
using the sequences of the S gene.
3.2. RFLP patterns
The alignment of S gene sequences was inspected to deter-
mine whether restriction sites could be identi¢ed that corre-
sponded to genotype-speci¢c sequences. Five restriction en-
zymes, HphI, NciI, AlwI, EarI and NlaIV, were identi¢ed
which should result in genotype-speci¢c RFLP from the S
gene region. Representative sequences from the S genome re-
gion of each HBV genotype were aligned to show the restric-
tion sites by the ¢ve restriction enzymes (Fig. 2). Genotype B
could be distinguished by the fact that the S gene fragment
was uncut by EarI, while no AlwI site was present in S gene
sequences of genotype C. Only genotype E had a restriction
site for NciI at position 461, and only genotype F had a
restriction site for HphI at position 82. For genotype A, the
speci¢c restriction enzyme site for NlaIV was not found at
position 299, but genotype D was digested at positions 265
and 299 by NlaIV. The pattern observed with these restriction
enzymes is shown in panels 1^4 of Fig. 3 and the strategy for
HBV genotyping using this approach is summarized in Fig. 4.
Firstly, genotype C is found by AlwI digestion, and secondly,
genotype B is identi¢ed using EarI. Thirdly, genotypes E and
F can be identi¢ed with HphI and NciI. Finally, the genotypes
A and D were identi¢ed by NlaIV (Fig. 4).
3.3. Veri¢cation of RFLP genotype assignment by sequence
analysis
Sequences of the 23 samples evaluated by RFLP were de-
termined and compared to representative S gene sequences
obtained from GenBank/DDBJ (n = 83) using the N-J method
for phylogenetic analysis (Fig. 5). S region sequences cluster
with the appropriate genotypes based upon phylogenetic anal-
ysis and con¢rm the validity of the RFLP technique.
4. Discussion
In this study, two important points are illustrated. Firstly,
we demonstrate that phylogenetic analysis of the S gene and
the full-length HBV genome by the N-J method generates
trees with clearly separated genetic clusters. This means that
genotypes for HBV can be assigned based upon S gene se-
quences. Secondly, a new simple HBV genotyping system has
been established using the RFLP method.
Serologic classi¢cation of HBV into the four major sub-
types, adr, adw, ayr and ayw [8], is based upon a limited
number of amino acids substitutions within the ‘a’ determi-
nant of HBsAg and serotypes do not strictly correlate with
genotypic classi¢cation [3,4,9]. Full-genomic sequences are the
ideal for genotype assignment, but sequence determination is
costly and time-consuming. To simplify classi¢cation of HBV
genotypes for new isolates, a genotyping method has been
developed using RFLP. HBV genotyping by RFLP is less
complicated compared to direct sequencing and sequence
analysis. In future it may be important to evaluate the etio-
logical or clinical relevance of HBV genotypes to predict the
progression of liver disease or to investigate routes of infec-
tion, and this simple and exact genotyping system will be
useful for these investigations.
In the past, other HBV genotyping systems using RFLP
analysis of a PCR product of the S gene or pre-S sequence
have been reported [10^12]. However, the HBV genotype of
11 isolates deduced from DDBJ/GenBank are not appropri-
ately classi¢ed by the RFLP system using the pre-S region
(data not shown). The sequence of the S gene is more con-
served than the pre-S region because the S gene overlaps the
reverse transcriptase active site in the P gene which is encoded
in a di¡erent frame [13]. Therefore, the S gene is more suitable
for genotyping than the pre-S region. Lindh et al. [12] also
reported HBV genotyping by RFLP using the S region, but
they did not analyze the topologies and the reliabilities of
trees generated using the S gene and full genome sequences.
In conclusion, the RFLP system that we have described in
relatively simple to interpret and is expected to be widely
used for clinical and etiological research of HBV.
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